The editors of the Italian Review of International and Comparative Law (IRIC) welcomes papers from scholars and practitioners at all stages of their career for the Volume 1 of 2023.
Papers may cover any topic, under public international law, private law and comparative law, of the issues related to the interaction between the EU legal order and international arbitration, including:
– The influence of EU law on the concept of arbitrability.
– The exclusion of commercial arbitration from the Bruxelles I-bis Regulation.
– The legal consequences of Brexit on international arbitration in Europe.
– The circulation of judgments concerning international arbitration within the EU;
– The future evolution of ISDS in the EU.
– The regulation of international investments between the EU, its Member States and third countries.
– Treaty law issues concerning the validity and the effectiveness of intra-EU bilateral investment treaties (BITs) and the use of public international law by the CJEU.
– The fate of the 1994 Energy Charter Treaty.
– The application of EU law by international arbitrators.
– International investment law before EU Member States domestic courts.
– The enforcement of arbitral decisions concerning intra-EU BITs in EU and third countries.
– EU law as a form of public policy precluding the enforcement of arbitral decisions.
– The potential effects of the CJEU’s decisions concerning international commercial arbitration or ISDS.
Papers containing also a reference to Italy, or the Italian practice will be particularly appreciated.
The selection of papers will be based on the submission of abstracts of max. 1.000 words to firstname.lastname@example.org by 1 April 2022. Selected authors will be informed by 30 April 2022.
Final papers will have to be submitted by 15 September 2022 and may have the forms of essays, comments, case notes, recent developments and review essays; each of the latter has a different range of words allowed. Submitted abstracts will have to mention the tentative title of the paper and the form expecred to be used.
Further information available here.